{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:47:02Z","timestamp":1793278022554,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB 2024NSCQ-KJFZZDX0033"],"award-info":[{"award-number":["CSTB 2024NSCQ-KJFZZDX0033"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-73278-8","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:53:52Z","timestamp":1782993232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage INSIG1 deficiency drives psoriasiform dermatitis via the SREBP2-STAT1 axis"],"prefix":"10.1038","volume":"17","author":[{"given":"Xiangzheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhuo","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-8116","authenticated-orcid":false,"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-2078","authenticated-orcid":false,"given":"Cheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-3164","authenticated-orcid":false,"given":"Lei","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-2734","authenticated-orcid":false,"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"73278_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong, A. W. et al. Psoriasis. Nat. Rev. Dis. Prim. 11, 45 (2025).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"73278_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb, J. E. et al. Psoriasis. Nat. Rev. Dis. Prim. 2, 16082 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"73278_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. Psoriasis. Lancet 397, 1301\u20131315 (2021).","journal-title":"Lancet"},{"key":"73278_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct. Target Ther. 8, 437 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"73278_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/jdv.18044","volume":"36","author":"JJ Wu","year":"2022","unstructured":"Wu, J. J., Kavanaugh, A., Lebwohl, M. G., Gniadecki, R. & Merola, J. F. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. J. Eur. Acad. Dermatol. Venereol. 36, 797\u2013806 (2022).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"73278_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103577","volume":"23","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Global prevalence of obesity in patients with psoriasis: an analysis in the past two decades. Autoimmun. Rev. 23, 103577 (2024).","journal-title":"Autoimmun. Rev."},{"key":"73278_CR7","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3390\/life13101947","volume":"13","author":"D Vata","year":"2023","unstructured":"Vata, D. et al. Update on obesity in psoriasis patients. Life 13, 1947 (2023).","journal-title":"Life"},{"key":"73278_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamadermatol.2024.4433","volume":"161","author":"A Svedbom","year":"2025","unstructured":"Svedbom, A. et al. Skin inflammation, systemic inflammation, and cardiovascular disease in psoriasis. JAMA Dermatol. 161, 81 (2025).","journal-title":"JAMA Dermatol."},{"key":"73278_CR9","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","volume":"56","author":"P Sivasami","year":"2023","unstructured":"Sivasami, P. et al. Obesity-induced dysregulation of skin-resident PPAR\u03b3+ treg cells promotes IL-17A-mediated psoriatic inflammation. Immunity 56, 1844\u20131861.e1846 (2023).","journal-title":"Immunity"},{"key":"73278_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/535612","volume":"2010","author":"A Pietrzak","year":"2010","unstructured":"Pietrzak, A., Michalak-Stoma, A., Chodorowska, G. & Szepietowski, J. C. Lipid disturbances in psoriasis: an update. Mediators Inflamm. 2010, 535612 (2010).","journal-title":"Mediators Inflamm."},{"key":"73278_CR11","first-page":"e52099","volume":"16","author":"WA Alajroush","year":"2024","unstructured":"Alajroush, W. A. et al. Psoriasis and metabolic disorders: a comprehensive meta-analysis of millions of adults worldwide. Cureus 16, e52099 (2024).","journal-title":"Cureus"},{"key":"73278_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2375580","volume":"35","author":"Y Liang","year":"2024","unstructured":"Liang, Y., Wang, Y., Peng, A., Li, J. & Zhang, K. Molecular mechanisms and drug therapy of metabolism disorders in psoriasis. J. Dermatol. Treat. 35, 2375580 (2024).","journal-title":"J. Dermatol. Treat."},{"key":"73278_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaad.2015.01.004","volume":"72","author":"M Gyldenl\u00f8ve","year":"2015","unstructured":"Gyldenl\u00f8ve, M. et al. Patients with psoriasis are insulin-resistant. J. Am. Acad. Dermatol 72, 599\u2013605 (2015).","journal-title":"J. Am. Acad. Dermatol"},{"key":"73278_CR14","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.jid.2025.05.002","volume":"145","author":"LBP M\u00f8ller","year":"2025","unstructured":"M\u00f8ller, L. B. P. et al. Spatial proteomic profiling reveals increased levels of cholesterol synthesis proteins in psoriasis vulgaris. J. Invest. Dermatol. 145, 3051\u20133063.e2 (2025).","journal-title":"J. Invest. Dermatol."},{"key":"73278_CR15","unstructured":"Fortinskaia E. S., et al. [Features of distribution of free and esterified cholesterol in the epidermis, biological membranes and plasma lipoproteins in psoriasis]. Klin. Lab. Diagn., 38-43 (1996)."},{"key":"73278_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101264","volume":"93","author":"D Mijaljica","year":"2024","unstructured":"Mijaljica, D., Townley, J. P., Spada, F. & Harrison, I. P. The heterogeneity and complexity of skin surface lipids in human skin health and disease. Prog. Lipid Res. 93, 101264 (2024).","journal-title":"Prog. Lipid Res."},{"key":"73278_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep19295","volume":"6","author":"P Varshney","year":"2016","unstructured":"Varshney, P. et al. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis. Sci. Rep. 6, 19295 (2016).","journal-title":"Sci. Rep."},{"key":"73278_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6656622","volume":"2021","author":"X Gong","year":"2021","unstructured":"Gong, X. & Wang, W. Profiles of innate immune cell infiltration and related core genes in psoriasis. Biomed. Res Int 2021, 6656622 (2021).","journal-title":"Biomed. Res Int"},{"key":"73278_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jdermsci.2018.01.005","volume":"90","author":"CTH Nguyen","year":"2018","unstructured":"Nguyen, C. T. H. et al. Up-regulated expression of CD86 on circulating intermediate monocytes correlated with disease severity in psoriasis. J. Dermatol Sci. 90, 135\u2013143 (2018).","journal-title":"J. Dermatol Sci."},{"key":"73278_CR20","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1111\/bph.17349","volume":"181","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Oroxylin A attenuates psoriasiform skin inflammation by directly targeting p62 (sequestosome 1) via suppressing M1 macrophage polarization. Br. J. Pharm. 181, 5110\u20135132 (2024).","journal-title":"Br. J. Pharm."},{"key":"73278_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114469","volume":"161","author":"Q Sun","year":"2023","unstructured":"Sun, Q., Hu, S., Lou, Z. & Gao, J. The macrophage polarization in inflammatory dermatosis and its potential drug candidates. Biomed. Pharmacother. 161, 114469 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"73278_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2022.05.015","volume":"352","author":"SA O\u2019Rourke","year":"2022","unstructured":"O\u2019Rourke, S. A. et al. Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages. Atherosclerosis 352, 35\u201345 (2022).","journal-title":"Atherosclerosis"},{"key":"73278_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1159\/000430365","volume":"37","author":"X Xu","year":"2015","unstructured":"Xu, X., Zhang, A., Li, N., Li, P. L. & Zhang, F. Concentration-dependent diversifcation effects of free cholesterol loading on macrophage viability and polarization. Cell Physiol. Biochem 37, 419\u2013431 (2015).","journal-title":"Cell Physiol. Biochem"},{"key":"73278_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.635923","volume":"12","author":"CM Ram\u00edrez","year":"2021","unstructured":"Ram\u00edrez, C. M. et al. Crosstalk between LXR and caveolin-1 signaling supports cholesterol efflux and anti-inflammatory pathways in macrophages. Front Endocrinol. (Lausanne) 12, 635923 (2021).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"73278_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07381-8","volume":"7","author":"H Kim","year":"2017","unstructured":"Kim, H. The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages. Sci. Rep. 7, 7591 (2017).","journal-title":"Sci. Rep."},{"key":"73278_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1550500","volume":"16","author":"JP Rodr\u00edguez","year":"2025","unstructured":"Rodr\u00edguez, J. P., Casas, J., Balboa, M. A. & Balsinde, J. Bioactive lipid signaling and lipidomics in macrophage polarization: Impact on inflammation and immune regulation. Front. Immunol. 16, 1550500 (2025).","journal-title":"Front. Immunol."},{"key":"73278_CR27","first-page":"3825","volume":"11","author":"F Dou","year":"2019","unstructured":"Dou, F. et al. Anti-atherosclerotic effects of LXR\u03b1 agonist through induced conversion of M1 macrophage to M2. Am. J. Transl. Res. 11, 3825\u20133840 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"73278_CR28","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.113.301086","volume":"112","author":"M Westerterp","year":"2013","unstructured":"Westerterp, M. et al. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ. Res. 112, 1456\u20131465 (2013).","journal-title":"Circ. Res."},{"key":"73278_CR29","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","volume":"118","author":"L Yvan-Charvet","year":"2008","unstructured":"Yvan-Charvet, L. et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118, 1837\u20131847 (2008).","journal-title":"Circulation"},{"key":"73278_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0092-8674(02)00872-3","volume":"110","author":"T Yang","year":"2002","unstructured":"Yang, T. et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489\u2013500 (2002).","journal-title":"Cell"},{"key":"73278_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.immuni.2014.11.011","volume":"41","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity 41, 919\u2013933 (2014).","journal-title":"Immunity"},{"key":"73278_CR32","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41418-022-00947-8","volume":"29","author":"T Xu","year":"2022","unstructured":"Xu, T. et al. Ubiquitination of NLRP3 by gp78\/Insig-1 restrains NLRP3 inflammasome activation. Cell Death Differ. 29, 1582\u20131595 (2022).","journal-title":"Cell Death Differ."},{"key":"73278_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2019.06.005","volume":"51","author":"A Kusnadi","year":"2019","unstructured":"Kusnadi, A. et al. The cytokine TNF promotes transcription factor SREBP activity and binding to inflammatory genes to activate macrophages and limit tissue repair. Immunity 51, 241\u2013257.e249 (2019).","journal-title":"Immunity"},{"key":"73278_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.immuni.2018.08.021","volume":"49","author":"C Guo","year":"2018","unstructured":"Guo, C. et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity 49, 842\u2013856.e847 (2018).","journal-title":"Immunity"},{"key":"73278_CR35","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.2147\/JIR.S492875","volume":"17","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Single-cell sequencing and machine learning integration to identify candidate biomarkers in psoriasis: INSIG1. J. Inflamm. Res 17, 11485\u201311503 (2024).","journal-title":"J. Inflamm. Res"},{"key":"73278_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri3671","volume":"14","author":"F Ginhoux","year":"2014","unstructured":"Ginhoux, F. & Jung, S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392\u2013404 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"73278_CR37","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.jid.2024.01.034","volume":"144","author":"EL Larson","year":"2024","unstructured":"Larson, E. L. et al. Circulating monocytes are predictive and responsive in moderate-to-severe plaque psoriasis subjects treated with apremilast. J. Invest Dermatol 144, 1963\u20131974.e1913 (2024).","journal-title":"J. Invest Dermatol"},{"key":"73278_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2566","volume":"4","author":"A Walter","year":"2013","unstructured":"Walter, A. et al. Aldara activates TLR7-independent immune defense. Nat. Commun. 4, 1560 (2013).","journal-title":"Nat. Commun."},{"key":"73278_CR39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","volume":"12","author":"H Wen","year":"2011","unstructured":"Wen, H. et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408\u2013415 (2011).","journal-title":"Nat. Immunol."},{"key":"73278_CR40","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","volume":"35","author":"Y Cai","year":"2011","unstructured":"Cai, Y. et al. Pivotal role of dermal IL-17-producing \u03b3\u03b4 T cells in skin inflammation. Immunity 35, 596\u2013610 (2011).","journal-title":"Immunity"},{"key":"73278_CR41","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.3390\/ijms20174170","volume":"20","author":"Y Gao","year":"2019","unstructured":"Gao, Y. et al. Human IL-23R cytokine-binding homology region-fc fusion protein ameliorates psoriasis via the decrease of systemic Th17 and ILC3 cell responses. Int. J. Mol. Sci. 20, 4170 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"73278_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.778755","volume":"13","author":"HF Zhou","year":"2022","unstructured":"Zhou, H. F. et al. Aloperine ameliorates IMQ-induced psoriasis by attenuating Th17 differentiation and facilitating their conversion to Treg. Front Pharm. 13, 778755 (2022).","journal-title":"Front Pharm."},{"key":"73278_CR43","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/JCI97426","volume":"128","author":"R Wu","year":"2018","unstructured":"Wu, R. et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J. Clin. Invest 128, 2551\u20132568 (2018).","journal-title":"J. Clin. Invest"},{"key":"73278_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1008942828960","volume":"8","author":"BE Clausen","year":"1999","unstructured":"Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & F\u00f6rster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265\u2013277 (1999).","journal-title":"Transgenic Res"},{"key":"73278_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11004","volume":"7","author":"T N\u00e9meth","year":"2016","unstructured":"N\u00e9meth, T., Futosi, K., Sitaru, C., Ruland, J. & M\u00f3csai, A. Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo. Nat. Commun. 7, 11004 (2016).","journal-title":"Nat. Commun."},{"key":"73278_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41590-021-01120-y","volume":"23","author":"M Bruchard","year":"2022","unstructured":"Bruchard, M. et al. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nat. Immunol. 23, 262\u2013274 (2022).","journal-title":"Nat. Immunol."},{"key":"73278_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.matbio.2017.12.002","volume":"68-69","author":"MV Nastase","year":"2018","unstructured":"Nastase, M. V. et al. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol. 68-69, 293\u2013317 (2018).","journal-title":"Matrix Biol."},{"key":"73278_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70211","volume":"13","author":"AHH Alshihmani","year":"2025","unstructured":"Alshihmani, A. H. H., Mahmoudi, M., Kheder, R. K., Fadaee, A. & Esmaeili, S. A. The M2 macrophages importance role in psoriasis. Immun. Inflamm. Dis. 13, e70211 (2025).","journal-title":"Immun. Inflamm. Dis."},{"key":"73278_CR49","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13238-018-0505-z","volume":"9","author":"Y Hou","year":"2018","unstructured":"Hou, Y. et al. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis. Protein Cell 9, 1027\u20131038 (2018).","journal-title":"Protein Cell"},{"key":"73278_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.immuni.2011.02.011","volume":"34","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34, 409\u2013421 (2011).","journal-title":"Immunity"},{"key":"73278_CR51","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang, N., Liang, H. & Zen, K. Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Front. Immunol. 5, 614 (2014).","journal-title":"Front. Immunol."},{"key":"73278_CR52","doi-asserted-by":"publisher","first-page":"1394108","DOI":"10.3389\/fimmu.2024.1394108","volume":"15","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts. Front. Immunol. 15, 1394108 (2024).","journal-title":"Front. Immunol."},{"key":"73278_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12872-024-03957-1","volume":"24","author":"G Jiang","year":"2024","unstructured":"Jiang, G. et al. LY86 facilitates ox-LDL-induced lipid accumulation in macrophages by upregulating SREBP2\/HMGCR expression. BMC Cardiovasc. Disord. 24, 289 (2024).","journal-title":"BMC Cardiovasc. Disord."},{"key":"73278_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107539","volume":"150","author":"MY Xiao","year":"2024","unstructured":"Xiao, M. Y. et al. Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response. Bioorg. Chem. 150, 107539 (2024).","journal-title":"Bioorg. Chem."},{"key":"73278_CR55","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1172\/JCI25614","volume":"115","author":"LJ Engelking","year":"2005","unstructured":"Engelking, L. J. et al. Schoenheimer effect explained-feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J. Clin. Invest. 115, 2489\u20132498 (2005).","journal-title":"J. Clin. Invest."},{"key":"73278_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111738","volume":"41","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages. Cell Rep. 41, 111738 (2022).","journal-title":"Cell Rep."},{"key":"73278_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cca.2020.05.042","volume":"508","author":"S Ouyang","year":"2020","unstructured":"Ouyang, S., Mo, Z., Sun, S., Yin, K. & Lv, Y. Emerging role of Insig-1 in lipid metabolism and lipid disorders. Clin. Chim. Acta 508, 206\u2013212 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"73278_CR58","doi-asserted-by":"publisher","first-page":"e142067","DOI":"10.1172\/jci.insight.142067","volume":"5","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y. et al. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight 5, e142067 (2020).","journal-title":"JCI Insight"},{"key":"73278_CR59","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ajpath.2024.01.014","volume":"194","author":"Z Tu","year":"2024","unstructured":"Tu, Z. et al. IL-6 up-regulates expression of LIM-domain only protein 4 in psoriatic keratinocytes through activation of the MEK\/ERK\/NF-\u03baB pathway. Am. J. Pathol. 194, 708\u2013720 (2024).","journal-title":"Am. J. Pathol."},{"key":"73278_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1104","volume":"11","author":"Z Tu","year":"2023","unstructured":"Tu, Z. et al. Pro-inflammatory cytokine IL-6 regulates LMO4 expression in psoriatic keratinocytes via AKT\/STAT3 pathway. Immun. Inflamm. Dis. 11, e1104 (2023).","journal-title":"Immun. Inflamm. Dis."},{"key":"73278_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3709749","volume":"2020","author":"WM Wang","year":"2020","unstructured":"Wang, W. M. & Jin, H. Z. Role of neutrophils in psoriasis. J. Immunol. Res 2020, 3709749 (2020).","journal-title":"J. Immunol. Res"},{"key":"73278_CR62","doi-asserted-by":"publisher","first-page":"941071","DOI":"10.3389\/fimmu.2022.941071","volume":"13","author":"M Kamata","year":"2022","unstructured":"Kamata, M. & Tada, Y. Dendritic cells and macrophages in the pathogenesis of psoriasis. Front. Immunol. 13, 941071 (2022).","journal-title":"Front. Immunol."},{"key":"73278_CR63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-4939-7837-3_24","volume":"1784","author":"J Shi","year":"2018","unstructured":"Shi, J., Hua, L., Harmer, D., Li, P. & Ren, G. Cre driver mice targeting macrophages. Methods Mol. Biol. 1784, 263\u2013275 (2018).","journal-title":"Methods Mol. Biol."},{"key":"73278_CR64","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202503615R","volume":"40","author":"S Huang","year":"2026","unstructured":"Huang, S. et al. Cre driver efficiency in myeloid lineages across tissues and in a model of myocardial injury. Faseb j. 40, e71497 (2026).","journal-title":"Faseb j."},{"key":"73278_CR65","doi-asserted-by":"publisher","first-page":"e0200013","DOI":"10.1371\/journal.pone.0200013","volume":"13","author":"A Ferro","year":"2018","unstructured":"Ferro, A. et al. Inhibition of NF-\u03baB signaling in IKK\u03b2F\/F;LysM Cre mice causes motor deficits but does not alter the pathogenesis of Spinocerebellar ataxia type 1. PLoS ONE 13, e0200013 (2018).","journal-title":"PLoS ONE"},{"key":"73278_CR66","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20120030","volume":"209","author":"AT Satpathy","year":"2012","unstructured":"Satpathy, A. T. et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209, 1135\u20131152 (2012).","journal-title":"J. Exp. Med."},{"key":"73278_CR67","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"D-I Jang","year":"2021","unstructured":"Jang, D.-I. et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int. J. Mol. Sci. 22, 2719 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"73278_CR68","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jdermsci.2018.05.009","volume":"91","author":"SH Lin","year":"2018","unstructured":"Lin, S. H., Chuang, H. Y., Ho, J. C., Lee, C. H. & Hsiao, C. C. Treatment with TNF-\u03b1 inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation. J. Dermatol Sci. 91, 276\u2013284 (2018).","journal-title":"J. Dermatol Sci."},{"key":"73278_CR69","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jid.2021.09.012","volume":"142","author":"A Ravipati","year":"2021","unstructured":"Ravipati, A. et al. IL-6R\/STAT3-signaling in keratinocytes rather than T cells induces psoriasis-like dermatitis in mice. J. Invest. Dermatol. 142, 1126\u20131135.e4 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"73278_CR70","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","volume":"18","author":"K Kikly","year":"2006","unstructured":"Kikly, K., Liu, L., Na, S. & Sedgwick, J. The IL-23\/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18, 670\u2013675 (2006).","journal-title":"Curr. Opin. Immunol."},{"key":"73278_CR71","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","volume":"190","author":"A Johnston","year":"2013","unstructured":"Johnston, A. et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.  J. Immunol. 190, 2252\u20132262 (2013).","journal-title":"J. Immunol."},{"key":"73278_CR72","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"S Liang","year":"2006","unstructured":"Liang, S. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance the expression of antimicrobial peptides.  J. Exp. Med. 203, 2271\u20132279 (2006).","journal-title":"J. Exp. Med."},{"key":"73278_CR73","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967\u2013974 (2007).","journal-title":"Nat. Immunol."},{"key":"73278_CR74","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/jnc.13408","volume":"136","author":"K Rochfort","year":"2016","unstructured":"Rochfort, K., Collins, L., McLoughlin, A. & Cummins, P. Tumour necrosis factor-\u03b1-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6. J. Neurochem. 136, 564\u2013572 (2016).","journal-title":"J. Neurochem."},{"key":"73278_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/gtc.13188","volume":"30","author":"K Yuasa","year":"2025","unstructured":"Yuasa, K. et al. Interferon-dependent expression of the human STAT1 gene requires a distal regulatory region located approximately 6\u2009kb upstream of its autoregulatory system. Genes Cells 30, e13188 (2025).","journal-title":"Genes Cells"},{"key":"73278_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/gtc.12316","volume":"21","author":"K Yuasa","year":"2016","unstructured":"Yuasa, K. & Hijikata, T. Distal regulatory element of the STAT1 gene potentially mediates positive feedback control of STAT1 expression. Genes Cells 21, 25\u201340 (2016).","journal-title":"Genes Cells"},{"key":"73278_CR77","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nn1440","volume":"8","author":"F He","year":"2005","unstructured":"He, F. et al. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat. Neurosci. 8, 616\u2013625 (2005).","journal-title":"Nat. Neurosci."},{"key":"73278_CR78","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836\u20135845 (2009).","journal-title":"J. Immunol."},{"key":"73278_CR79","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1158\/2326-6066.CIR-17-0035","volume":"6","author":"C Li","year":"2018","unstructured":"Li, C. et al. Peptide blocking of PD-1\/PD-L1 interaction for cancer immunotherapy. Cancer Immunol. Res. 6, 178\u2013188 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"73278_CR80","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/jid.2015.249","volume":"135","author":"Y Yamaguchi","year":"2015","unstructured":"Yamaguchi, Y., Watanabe, Y., Watanabe, T., Komitsu, N. & Aihara, M. Decreased expression of caveolin-1 contributes to the pathogenesis of psoriasiform dermatitis in mice. J. Invest Dermatol 135, 2764\u20132774 (2015).","journal-title":"J. Invest Dermatol"},{"key":"73278_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.81","volume":"49","author":"YJ Jeon","year":"2017","unstructured":"Jeon, Y. J. et al. Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice. Exp. Mol. Med. 49, e349 (2017).","journal-title":"Exp. Mol. Med."},{"key":"73278_CR82","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.jid.2022.01.012","volume":"142","author":"J Ma","year":"2022","unstructured":"Ma, J. et al. LCN2 mediates skin inflammation in psoriasis through the SREBP2\u2012NLRC4 axis. J. Invest. Dermatol. 142, 2194\u20132204.e2111 (2022).","journal-title":"J. Invest. Dermatol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73278-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:03:32Z","timestamp":1786665812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73278-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73278"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73278-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8386"}}